CORAL study chair Lance Dworkin, MD, discusses the controversial finding with Renal & Urology News.
Geriatric patients with CKD are at high risk for morbidity and mortality from the potential side effects of treatments.
Weight cycling linked to increased diabetes risk, even after adjustment for baseline weight.
Whey pre-load linked to reduction in glucose levels, improved early insulin response, GLP-1 levels.
Use of the drug reduced the risk of recurrence and cancer-related mortality in diabetic patients undergoing radical cystectomy.
Afrezza is administered at the start of each meal or within 20 minutes after starting a meal.
Obesity a major risk factor for condition, experts say.
African-American patients with diabetes have a better glycemic response to metformin.
Target of less than 7.0% recommended for all pediatric patients; less than 7.5% for adults.
Other oral hypoglycemic agents have no effect on the risk.
Improvements in depressive symptoms, well-being, distress with MBCT, CBT.
Over the study period there was widespread adoption of insulin analogs; out-of-pocket costs up.
Low vitamin D linked to metabolic dysfunction only when accompanied by elevated PTH.
Research suggests greater success in weight loss, DM remission compared to lifestyle changes.
Deaths include fatal poisonings caused by overdoses of insulin or hypoglycemic drugs.
Effect on diabetes risk, inflammation found independent of sleep loss in males.
Other risk factors include diabetes, increasing age, and increasing dialysis vintage; higher albumin levels reduce the risk.